GlobeNewswire Clinical StudiesOriginal article
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
Data ReadoutpositiveFFRCT AnalysisPositive
AI Analysis
Summary
Late-breaking FUSION trial data presented at ESC shows Heartflow's FFRCT non-invasive analysis reduces unnecessary invasive cardiac procedures by nearly 50% and resolves diagnostic uncertainty in coronary artery disease evaluation.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
FUSION trial demonstrated FFRCT analysis reduces unnecessary invasive heart procedures by nearly half and resolves critical diagnostic uncertainty
Importance:7/10
Sentiment:
0.80
cardiologydiagnosticclinical trialESC presentationFUSION trialJACC publication
Related Companies
Read the original article
Published by GlobeNewswire Clinical Studies on August 28, 2026 6:48 AM